Loading…
The company expands its market reach and establishes key partnerships.
Catheter Precision, Inc. (NYSE: VTAK) has announced significant commercial advancements. The company has entered into a partnership with Cardinal Health, secured a collaboration with Johns Hopkins, and successfully placed the first VIVO System in Germany.
These milestones mark important steps in Catheter Precision's expansion into new markets and strengthening of its distribution network. The partnership with Cardinal Health is expected to enhance the company's reach in the medical supply chain, while the collaboration with Johns Hopkins aims to foster innovation and research in catheter technology. The placement of the VIVO System in Germany signifies the company's entry into the European market.
With a free float of 2,325,166 shares, Catheter Precision continues to build its presence in the healthcare equipment sector.
This summary was generated by AI from public sources and may contain errors. Not financial advice. Trade at your own risk.